Concepedia

Sake J. van der Wall

SJ

Statistics

Publications

6

Citations

206

H-Index

6

Active since

2016

Affiliations

Leiden University Medical Center(Current)

Instituto Ramón y Cajal de Investigación Sanitaria

Sake J. van der Wall is an author at Leiden University Medical Center specializing in thrombosis, medicine, and anticoagulant therapy.

ORCID

Publications per year

2016–2020

6

Publications

6

Continuation of low‐molecular‐weight heparin treatment for cancer‐related venous thromboembolism: a prospective cohort study in daily clinical practice

Sake J. van der Wall, Frederikus A. Klok, Paul L. den Exter et al. · Journal of Thrombosis and Haemostasis · 2016 · 65 citations

, , +15

Idarucizumab for Dabigatran Reversal in the Management of Patients With Gastrointestinal Bleeding

Sake J. van der Wall, Renato D. Lópes, James Aisenberg et al. · Circulation · 2019 · 48 citations

, , +17

Performance of idarucizumab as antidote of dabigatran in daily clinical practice

Sake J. van der Wall, Nienke van Rein, Bart J. F. van den Bemt et al. · EP Europace · 2018 · 40 citations · Full text

, , +17

Antithrombotic therapy after mitral valve repair: VKA or aspirin?

Sake J. van der Wall, Jules R. Olsthoorn, Samuel Heuts et al. · Journal of Thrombosis and Thrombolysis · 2018 · 33 citations · Full text

, , +17

Higher Adherence to Treatment With Low‐Molecular‐Weight‐Heparin Nadroparin Than Enoxaparin Because of Side Effects in Cancer‐Associated Venous Thromboembolism

Sake J. van der Wall, Frederikus A. Klok, Paul L. den Exter et al. · HemaSphere · 2018 · 10 citations · Full text

, , +14

1–5 of 6